Moleculin Biotech, Inc. (NASDAQ:MBRX – Get Free Report) saw a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 21,100 shares, a drop of 38.3% from the May 15th total of 34,200 shares. Based on an average daily volume of 40,200 shares, the days-to-cover ratio […]
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the stock. A number of other research analysts also recently commented on the company. Maxim Group dropped their price objective on Moleculin Biotech from $45.00 to $20.00 and set […]
StockNews.com Initiates Coverage on Moleculin Biotech (NASDAQ:MBRX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Moleculin Biotech (NASDAQ:MBRX) Now Covered by StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the stock. A number of other brokerages have also issued reports on MBRX. Maxim Group dropped their price target on shares of Moleculin Biotech from $45.00 to $20.00 […]